Morel P - Search Results

1

Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study.

Fardet L, Cabane J, Lebbé C, Morel P, Flahault A. Fardet L, et al. Among authors: morel p. J Am Acad Dermatol. 2007 Oct;57(4):604-9. doi: 10.1016/j.jaad.2007.04.018. Epub 2007 Jun 19. J Am Acad Dermatol. 2007. PMID: 17582650 Clinical Trial.

2

Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.

Fardet L, Dupuy A, Kerob D, Levy A, Allez M, Begon E, Bachelez H, Morel P, Lebbé C. Fardet L, et al. Among authors: morel p. J Am Acad Dermatol. 2007 Apr;56(4):624-8. doi: 10.1016/j.jaad.2006.07.027. Epub 2007 Jan 22. J Am Acad Dermatol. 2007. PMID: 17240478

3

Incidence, risk factors, and severity of herpesvirus infections in a cohort of 121 patients with primary dermatomyositis and dermatomyositis associated with a malignant neoplasm.

Fardet L, Rybojad M, Gain M, Kettaneh A, Cherin P, Bachelez H, Dubertret L, Lebbe C, Morel P, Dupuy A. Fardet L, et al. Among authors: morel p. Arch Dermatol. 2009 Aug;145(8):889-93. doi: 10.1001/archdermatol.2009.152. Arch Dermatol. 2009. PMID: 19687419

4

Regression of CD8+ pseudolymphoma after HIV antiviral triple therapy.

Schartz NE, De La Blanchardiére A, Alaoui S, Morel P, Sigaux F, Vignon-Pennamen MD, Flageul B, Lebbé C. Schartz NE, et al. Among authors: morel p. J Am Acad Dermatol. 2003 Jul;49(1):139-41. doi: 10.1067/mjd.2003.299. J Am Acad Dermatol. 2003. PMID: 12833028

5

Treatment of cutaneous sarcoidosis with thalidomide.

Nguyen YT, Dupuy A, Cordoliani F, Vignon-Pennamen MD, Lebbé C, Morel P, Rybojad M. Nguyen YT, et al. Among authors: morel p. J Am Acad Dermatol. 2004 Feb;50(2):235-41. doi: 10.1016/j.jaad.2003.07.006. J Am Acad Dermatol. 2004. PMID: 14726878 Clinical Trial.

6

A retrospective analysis of thalidomide therapy in non-HIV-related Kaposi's sarcoma.

Ben M'barek L, Fardet L, Mebazaa A, Thervet E, Biet I, Kérob D, Morel P, Lebbe C. Ben M'barek L, et al. Among authors: morel p. Dermatology. 2007;215(3):202-5. doi: 10.1159/000106576. Dermatology. 2007. PMID: 17823515

7

Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients.

Célestin Schartz NE, Chevret S, Paz C, Kerob D, Verola O, Morel P, Lebbé C. Célestin Schartz NE, et al. Among authors: morel p. J Am Acad Dermatol. 2008 Apr;58(4):585-91. doi: 10.1016/j.jaad.2007.11.005. Epub 2008 Feb 20. J Am Acad Dermatol. 2008. PMID: 18068265 Clinical Trial.

8

Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis.

Fardet L, Dupuy A, Gain M, Kettaneh A, Chérin P, Bachelez H, Dubertret L, Lebbe C, Morel P, Rybojad M. Fardet L, et al. Among authors: morel p. Medicine (Baltimore). 2009 Mar;88(2):91-97. doi: 10.1097/MD.0b013e31819da352. Medicine (Baltimore). 2009. PMID: 19282699 Free article.

9

Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy.

Viguier M, Fouéré S, de la Salmonière P, Rabian C, Lebbe C, Dubertret L, Morel P, Bachelez H. Viguier M, et al. Among authors: morel p. Medicine (Baltimore). 2003 Mar;82(2):82-6. doi: 10.1097/00005792-200303000-00002. Medicine (Baltimore). 2003. PMID: 12640184 Free article.

10

Quality of abstracts in 3 clinical dermatology journals.

Dupuy A, Khosrotehrani K, Lebbé C, Rybojad M, Morel P. Dupuy A, et al. Among authors: morel p. Arch Dermatol. 2003 May;139(5):589-93. doi: 10.1001/archderm.139.5.589. Arch Dermatol. 2003. PMID: 12756095 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,880 results

Search Page

Filters